A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of GM1 Gangliosidosis or GM2 Gangliosidosis
PHASE3
An 18-month double-blind, randomized, placebo-controlled, multicenter, Phas...
Status
Active Not Recruiting
Location
UCSF Children's Hospital and Research Center at Oakland
Natural History Study for Pediatric Patients With Early Onset of Either GM1 Gangliosidosis, GM2 Gangliosidoses, or Gaucher Disease Type 2
N/A
This study is being conducted to better understand the natural course of GM...
Status
Completed
Location
Ann & Robert H. Lurie Children's Hospital of Chicago
Start Date
2019-07-31
Trial ID
NCT04470713
A Natural History Study of the Gangliosidoses
N/A
Hypothesis: To characterize and describe disease progression and heterogene...
Status
Recruiting
Location
University of Minnesota - Pediatric Genetics and Metabolism
Start Date
2010-12
Trial ID
NCT00668187
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis
PHASE3
An 18-month double-blind, randomized, placebo-controlled, multicenter, Phas...
Status
Recruiting
Location
UCSF Children's Hospital and Research Center at Oakland